person · Reporting owner
Smith Michael Alexander
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Chief Legal Officer | June 22, 2026 | June 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date June 22, 2026 · Filed June 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,648 |
Reported balance
After 2026-06-22 transaction · row 1
1 source rowRow 1 · 2026-06-22 · Sale · Disposed 1,806 · Balance 37,648 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2025 Filed Jan 10, 2025 23:44 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 319 | $63.38 | $20,218.22 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,965 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,370 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · derivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,370 Underlying: Common Stock · 27,370 shares Expires 2035-01-08 F6 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,706 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,284 F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:44 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,064 | $66.21 | $70,447.44 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,578 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:44 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 2,306 | $65.98 | $152,149.88 |
DisclosureSEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,642 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,306 shares sold at prices ranging from $65.96 to $66.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Includes 92 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · derivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 9,000 | $74.75 | $672,750.00 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,856 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 9,000 shares sold at prices ranging from $74.61 to $74.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 18,871 | $74.16 | $1,399,473.36 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,856 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 18,871 shares sold at prices ranging from $73.61 to $74.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:47 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 7,000 | $22.76 | $159,320.00 |
DisclosureSEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 34,530 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · derivative · entry 8 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,530 Underlying: Common Stock · 34,530 shares Expires 2032-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the date of grant. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 41,640 | $0.00 Strike: $13.91 | $0.00 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · derivative · entry 7 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,640 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 11,900 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · derivative · entry 6 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,900 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 20,415 | $73.65 | $1,503,564.75 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,727 F2 · price: This is the weighted average sales price representing 20,415 shares sold at prices ranging from $73.22 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 67,655 | $72.75 | $4,921,901.25 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,142 F1 · price: This is the weighted average sales price representing 67,655 shares sold at prices ranging from $72.22 to $73.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 34,530 | $17.07 | $589,427.10 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 41,640 | $13.91 | $579,212.40 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:28 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 11,900 | $17.16 | $204,204.00 |
DisclosureSEC source: 0001628280-24-037226 · wk-form4_1723667301.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 21:19 UTC | INSMED Inc INSM · Entity 3174 | Tax withholdingCommon Stock | 730 | $70.05 | $51,136.50 |
DisclosureSEC source: 0001628280-24-031618 · wk-form4_1720646371.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,727 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2 · price: Represents the closing price of Common Stock on the vesting date of the RSUs. F3 · balance_after: Includes 629 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 14,810 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 11 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,810 shares Expires 2027-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 3,470 | $0.00 Strike: $11.38 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 10 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,470 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 3,691 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 9 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,691 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.16 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 8 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $16.07 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 7 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 44,722 | $49.53 | $2,215,080.66 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 6 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,828 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 14,810 | $13.67 | $202,452.70 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 3,470 | $11.38 | $39,488.60 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 3,691 | $10.85 | $40,047.35 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 10,000 | $16.16 | $161,600.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 7,000 | $16.07 | $112,490.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:37 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 5,093 | $25.40 | $129,362.20 |
DisclosureSEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,579 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 5,093 shares sold at prices ranging from $25.38 to $25.42 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:37 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 65,230 | $0.00 Strike: $25.83 | $0.00 |
DisclosureSEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · derivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,230 Underlying: Common Stock · 65,230 shares Expires 2034-05-13 F5 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:37 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 13,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,672 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 13, 2024 for no consideration. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 2,373 | $28.76 | $68,247.48 |
DisclosureSEC source: 0001628280-24-001165 · wk-form4_1705007495.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,364 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,373 shares sold at prices ranging from $28.75 to $28.79 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:32 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 627 | $29.31 | $18,374.24 |
DisclosureSEC source: 0001628280-24-000697 · wk-form4_1704493968.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,737 F4 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 22:32 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 58,260 | $0.00 Strike: $29.13 | $0.00 |
DisclosureSEC source: 0001628280-24-000697 · wk-form4_1704493968.xml · derivative · entry 3 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,260 Underlying: Common Stock · 58,260 shares Expires 2034-01-04 F5 · derivative.exercise_date: Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 22:32 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 11,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-000697 · wk-form4_1704493968.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,364 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration. F3 · balance_after: Includes 422 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:01 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 740 | $20.18 | $14,933.20 |
DisclosureSEC source: 0001140361-23-034422 · form4.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,142 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · balance_after: Includes 800 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 17, 2023 Filed May 17, 2023 20:14 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,263 | $18.18 | $22,961.34 |
DisclosureSEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,082 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:14 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 475 | $18.43 | $8,754.25 |
DisclosureSEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,345 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F3 · price: This is the weighted average sales price representing 475 shares sold at prices ranging from $18.40 to $18.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:14 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,897 | $19.24 | $36,498.28 |
DisclosureSEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,820 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 1,897 shares sold at prices ranging from $19.24 to $19.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:14 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 121,850 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · derivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,850 Underlying: Common Stock · 121,850 shares Expires 2033-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:14 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 26,385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,717 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:13 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,836 | $17.93 | $32,919.48 |
DisclosureSEC source: 0001628280-23-000962 · wf-form4_167355796596777.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,332 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 1,836 shares sold at prices ranging from $17.92 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 29,050 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · derivative · entry 3 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,050 Underlying: Common Stock · 29,050 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 6,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,168 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 720 | $19.72 | $14,198.40 |
DisclosureSEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,836 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · balance_after: Includes 101 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| July 12, 2022 Filed Jul 12, 2022 20:06 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 941 | $23.40 | $22,019.40 |
DisclosureSEC source: 0001870278-22-000001 · wf-form4_165765636118954.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,455 F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F2 · balance_after: Includes 813 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:07 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,055 | $20.37 | $21,490.35 |
DisclosureSEC source: 0001140361-22-019785 · form4.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,583 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $20.33 to $20.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:07 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 433 | $18.48 | $8,001.84 |
DisclosureSEC source: 0001140361-22-019785 · form4.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,638 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. Read SEC document |
| May 11, 2022 Filed May 13, 2022 22:13 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 69,060 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001140361-22-019175 · form4.xml · derivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,060 Underlying: Common Stock · 69,060 shares Expires 2032-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.